In line with this, an increase in exhausted T cells (expressing PD-1) has previously been found in COVID-19 patients, which showed a relationship with their clinical outcomes, suggesting that the expression of PD-1 on T cells may be a risk factor for unfavorable outcomes in these patients (40). Here, PDCD1 is linked to COVID-19.